• Home
  • Games
  • Live Games
  • Live Slots
  • Slot Games
  • Poker
  • Fishing
  • Sports
  • Community
  • Promotions
  • Account
English

Maccabi Raanana VS Gilboa Galil

4 days ago
Reads 35
Plan Details
【Winner】4 days agoISL
Maccabi Raanana
Maccabi Raanana
71 : 89
Gilboa Galil
Gilboa Galil
Home Win
2.5
Guest Win
1.5
Bet Now!casinoplus_logo
This odds are at the time of recommendation, not real-time odds
Recommend Reasons
Description

This basketball Super League match will be played on January 27, 2026 at 00:30 (Manila time, Philippines), with the home team Maccabi Rana playing away team Kilipo Galil, and the prediction result is an away win.

Recent record

Maccabi Lanana has been in ups and downs recently, with obvious loopholes on the defensive end and inconsistent home performance. Kilipogalil has a better record recently, with a balanced performance at both ends of the offensive and defensive ends, and a strong ability to score points on the road.

Historical head-to-head

records between the two teams show that Kilipogalil has a certain psychological advantage, with a high winning rate in recent matchups and a record of winning away from home.

Odds:

The odds of this winning game are 2.5 for home wins and 0 draws (Note: "0" here may indicate that there is no draw option or incorrect data, and there is usually no draw in the basketball Super League), and the away win is 1.5. The odds of an away win of 1.5 are significantly lower than that of a home win, indicating that the market and institutions are clearly optimistic about the victory of the away team Kilibogalil.

Forecast

Based on recent form, historical head-to-head and odds data, the away team Kilipo Galil has the advantage in strength and form, and the market is confident. It is predicted that Kilipo Galil will win away from home in this game.

Do Not Bet

This analysis is for sports research purposes only and does not constitute any betting advice. Please look at sports competitions rationally and abide by relevant laws and regulations.

Other Experts' Picks

No Data Available